HOME > COMMENTARY
COMMENTARY
-
COMMENTARY/Original and Generic Makers Should Cooperate for Stable Supply
September 11, 2006
-
COMMENTARY Government Increases Efforts to Promote Clinical Research
September 4, 2006
-
TOPICS 2 articles
August 28, 2006
-
COMMENTARY/Government Increases Efforts to Promote Clinical Research
August 28, 2006
-
Blockbuster Sales of International Majors in 2005: Rankings of Companies and Therapeutic Areas Keiji Nakamura, Ph.D. Pharma Forum Institute, Kamakura, Japan http://www.pharma-fi.com/index.html
August 21, 2006
-
COMMENTARY 3 articles
August 7, 2006
-
5 Major New Drugs Affected by Listing of 1st Generics
July 31, 2006
-
COMMENTARY:New Clinical Trial Stimulation Plan to Go in Tandem with New Industry Vision
July 17, 2006
-
COMMENTARY Social Security Spending to Be Cut by \1.6 Tril.↓
July 10, 2006
-
COMMENTARY Amended PAL to Remake Retail Industry
July 10, 2006
-
Generic Drug Market Sees New Era of Competition 5 articles
July 3, 2006
-
Drug Industry Reorganization in the Future ―No More Argument, Unexpected Leaders?―
June 19, 2006
-
COMMENTARY 3 articles
June 19, 2006
-
Predicting the Future Market for Smoking Cessation Aids: Will OTC Products Continue to Outsell Ethical Products?
June 5, 2006
-
Major Domestic Companies Invest More Than Ever in R&D
May 29, 2006
-
Incident in PI Trial in UK 5 articles
May 8, 2006
-
New Prescription Form Shaking Things Up at Pharmacies
April 24, 2006
-
COMMENTARY 3 articles
April 24, 2006
-
Proposed Increases in Frequency of NHI Price Revisions
April 17, 2006
-
JMA Needs to Establish New Partnership with LDP
April 17, 2006
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…